Mark E. Johns
Expertise in
83
conditions

Dr. Mark E. Johns

Hematology Oncology | Oncology
601 Ivy Gateway, Suite 1100, 
Cincinnati, OH 
Accepting New Patients
Referral may be required
Before you request
Expertise in
83
conditions
601 Ivy Gateway, Suite 1100, 
Cincinnati, OH 

Overview

Mark Johns is a Hematologist Oncology specialist and an Oncologist practicing medicine in Cincinnati, Ohio.

Dr. Johns is highly rated in 83 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration.

Dr. Johns is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, participating in 2 clinical trials. Dr. Johns is currently accepting new patients.

Specialties

Hematology Oncology
Oncology

Licenses

Internal Medicine in MN

Board Certifications

American Board Of Internal Medicine

Fellowships

University Of South Florida, Hematology & Oncology, 2008

Hospital Affiliations

Mercy Health - West Hospital
The Jewish Hospital - Mercy Health
Mercy Health - Fairfield Hospital
Mercy Health - Clermont Hospital
Mercy Health - Anderson Hospital
Mercy Health-Anderson Hospital
Bethesda North
The Jewish Hospital-Mercy Health
Mercy Health - Clermont Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

Oncology Hematology Care, Inc
601 Ivy Gateway, Suite 1100, Cincinnati, OH 45245

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized Phase 2/3 Multi-Center Study of SM-88 in Subjects With Pancreatic Cancer Whose Disease Has Progressed or Recurred
A Randomized Phase 2/3 Multi-Center Study of SM-88 in Subjects With Pancreatic Cancer Whose Disease Has Progressed or Recurred
Enrollment Status: Terminated
Publish Date: November 06, 2024
Intervention Type: Drug
Study Drugs: SM-88, MPS (methoxsalen, phenytoin, sirolimus), Capecitabine, Gemcitabine, 5-FU
Study Phase: Phase 2/Phase 3
Randomized Study of AM0010 in Combination With FOLFOX Compared to FOLFOX Alone as Second-line Tx in Pts With Metastatic Pancreatic Cancer That Has Progressed During or Following a First-Line Gemcitabine Containing Regimen
Randomized Study of AM0010 in Combination With FOLFOX Compared to FOLFOX Alone as Second-line Tx in Pts With Metastatic Pancreatic Cancer That Has Progressed During or Following a First-Line Gemcitabine Containing Regimen
Enrollment Status: Completed
Publish Date: October 19, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 3
View 1 Less Clinical Trial
Similar Doctors
Expertise in
54
conditions
Dr. David M. Waterhouse
Hematology Oncology | Oncology
Expertise in
54
conditions
Dr. David M. Waterhouse
Hematology Oncology | Oncology
Referral may be required
Before you request

Oncology Hematology Care, Inc

3301 Mercy Health Boulevard, Suite 100, 
Cincinnati, OH 
 (18.0 miles away)
888-649-4800
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Waterhouse is a Hematologist Oncology specialist and an Oncologist practicing medicine in Cincinnati, Ohio. Dr. Waterhouse is highly rated in 54 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Colorectal Cancer. Dr. Waterhouse is board certified in American Board Of Internal Medicine. Dr. Waterhouse is currently accepting new patients.

Expertise in
83
conditions
Dr. David R. Drosick
Hematology Oncology | Oncology
Expertise in
83
conditions
Dr. David R. Drosick
Hematology Oncology | Oncology
Referral may be required
Before you request

Oncology Hematology Care, Inc

601 Ivy Gateway, Suite 1100, 
Cincinnati, OH 
 (0.1 miles away)
888-649-4800
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Drosick is a Hematologist Oncology specialist and an Oncologist practicing medicine in Cincinnati, Ohio. Dr. Drosick is highly rated in 83 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Common Variable Immune Deficiency, Bone Marrow Aspiration, and Gastrostomy. Dr. Drosick is board certified in American Board Of Internal Medicine. Dr. Drosick is currently accepting new patients.

Expertise in
81
conditions
Dr. Benjamin T. Herms
Hematology Oncology | Oncology
Expertise in
81
conditions
Dr. Benjamin T. Herms
Hematology Oncology | Oncology
Referral may be required
Before you request

Oncology Hematology Care, Inc

601 Ivy Gateway, Suite 1100, 
Cincinnati, OH 
 (0.1 miles away)
888-649-4800
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Benjamin Herms is a Hematologist Oncology specialist and an Oncologist practicing medicine in Cincinnati, Ohio. Dr. Herms is highly rated in 81 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Herms is board certified in American Board Of Internal Medicine. Dr. Herms is currently accepting new patients.

Frequently Asked Questions about Dr. Mark E. Johns

How do I make an appointment with Dr. Mark E. Johns?

You can book an appointment with Dr. Mark E. Johns by calling their office at 888-649-4800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark E. Johns a top-rated expert for Paget Disease of the Breast?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark E. Johns is classified as an Distinguished expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark E. Johns specialize in?

While Dr. Mark E. Johns is a Hematology Oncology, they have specific expertise in Paget Disease of the Breast, Breast Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.

Does Dr. Mark E. Johns accept my insurance?

Dr. Mark E. Johns accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 888-649-4800 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Johns's expertise for a condition
ConditionClose
    View All 12 Distinguished Conditions
    View All 71 Advanced Conditions
    View All 138 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile